96 related articles for article (PubMed ID: 7752194)
21. Polycyclic aryl- and heteroarylpiperazinyl imides as 5-HT1A receptor ligands and potential anxiolytic agents: synthesis and structure-activity relationship studies.
Abou-Gharbia M; Patel UR; Webb MB; Moyer JA; Andree TH; Muth EA
J Med Chem; 1988 Jul; 31(7):1382-92. PubMed ID: 2898533
[TBL] [Abstract][Full Text] [Related]
22. Graphics computer-aided receptor mapping as a predictive tool for drug design: development of potent, selective, and stereospecific ligands for the 5-HT1A receptor.
Hibert MF; Gittos MW; Middlemiss DN; Mir AK; Fozard JR
J Med Chem; 1988 Jun; 31(6):1087-93. PubMed ID: 3373482
[TBL] [Abstract][Full Text] [Related]
23. 6-Hydroxybuspirone is a major active metabolite of buspirone: assessment of pharmacokinetics and 5-hydroxytryptamine1A receptor occupancy in rats.
Wong H; Dockens RC; Pajor L; Yeola S; Grace JE; Stark AD; Taub RA; Yocca FD; Zaczek RC; Li YW
Drug Metab Dispos; 2007 Aug; 35(8):1387-92. PubMed ID: 17494642
[TBL] [Abstract][Full Text] [Related]
24. Ligand induced conformational states of the 5-HT(1A) receptor.
Sylte I; Bronowska A; Dahl SG
Eur J Pharmacol; 2001 Mar; 416(1-2):33-41. PubMed ID: 11282110
[TBL] [Abstract][Full Text] [Related]
25. 1-aryl-4-[(5-methoxy-1,2,3, 4-tetrahydronaphthalen-1-yl)alkyl]piperazines and their analogues: influence of the stereochemistry of the tetrahydronaphthalen-1-yl nucleus on 5-HT1A receptor affinity and selectivity versus alpha1 and D2 receptors. 5.
Perrone R; Berardi F; Colabufo NA; Leopoldo M; Tortorella V
J Med Chem; 1999 Feb; 42(3):490-6. PubMed ID: 9986719
[TBL] [Abstract][Full Text] [Related]
26. Synthesis and pharmacological screening of some N,N'-bis-[4-(4-aryl-1-piperazinyl)butyl]-substituted derivatives of 1,8-dimethylbicyclo-[2.2.2]oct-7-ene-2,3,5,6-tetracarboxydiimide.
Turło J; Zawadowski T; Rump S; Jakowicz I; Gidyńska T; Gałecka E
Pol J Pharmacol; 1994; 46(5):451-5. PubMed ID: 7894533
[TBL] [Abstract][Full Text] [Related]
27. 1-Aryl-4-(4-succinimidobutyl)piperazines and their conformationally constrained analogues: synthesis, binding to serotonin (5-HT1A, 5-HT2A, 5-HT7), alpha1-adrenergic, and dopaminergic D2 receptors, and in vivo 5-HT1A functional characteristics.
Bojarski AJ; Paluchowska MH; Duszyńska B; Kłodzińska A; Tatarczyńska E; Chojnacka-Wójcik E
Bioorg Med Chem; 2005 Mar; 13(6):2293-303. PubMed ID: 15727878
[TBL] [Abstract][Full Text] [Related]
28. Synthesis, 5-HT1A and 5-HT2A receptor activity of new 1-phenylpiperazinylpropyl derivatives with arylalkyl substituents in position 7 of purine-2,6-dione.
Chloń G; Pawłowski M; Duszyńska B; Szaro A; Tatarczńska E; Kłodzińska AL; Chojnacka-Wójcik E
Pol J Pharmacol; 2001; 53(4):359-68. PubMed ID: 11990082
[TBL] [Abstract][Full Text] [Related]
29. Effect of acute administration of the 5-HT1A receptor ligand, lesopitron, on rat cortical 5-HT and dopamine turnover.
Ballarín M; Carceller A; Guitart X
Br J Pharmacol; 1994 Oct; 113(2):425-30. PubMed ID: 7530571
[TBL] [Abstract][Full Text] [Related]
30. 5-HT1A receptor activation and antidepressant-like effects: F 13714 has high efficacy and marked antidepressant potential.
Koek W; Vacher B; Cosi C; Assié MB; Patoiseau JF; Pauwels PJ; Colpaert FC
Eur J Pharmacol; 2001 May; 420(2-3):103-12. PubMed ID: 11408031
[TBL] [Abstract][Full Text] [Related]
31. Buspirone analogues. 2. Structure-activity relationships of aromatic imide derivatives.
New JS; Yevich JP; Eison MS; Taylor DP; Eison AS; Riblet LA; VanderMaelen CP; Temple DL
J Med Chem; 1986 Aug; 29(8):1476-82. PubMed ID: 2874226
[TBL] [Abstract][Full Text] [Related]
32. BMY 7378, a buspirone analog with high affinity, selectivity and low intrinsic activity at the 5-HT1A receptor in rat and guinea pig hippocampal membranes.
Yocca FD; Hyslop DK; Smith DW; Maayani S
Eur J Pharmacol; 1987 Jun; 137(2-3):293-4. PubMed ID: 2886356
[No Abstract] [Full Text] [Related]
33. Conformational analysis and geometry optimization of buspirone-A 5-HT1A receptor agonist.
Ikram H; Azhar M; Jameel M; Bano K
Pak J Pharm Sci; 2014 Sep; 27(5 Spec no):1515-22. PubMed ID: 25176246
[TBL] [Abstract][Full Text] [Related]
34. 5-HT1A-versus D2-receptor selectivity of flesinoxan and analogous N4-substituted N1-arylpiperazines.
Kuipers W; Kruse CG; van Wijngaarden I; Standaar PJ; Tulp MT; Veldman N; Spek AL; IJzerman AP
J Med Chem; 1997 Jan; 40(3):300-12. PubMed ID: 9022796
[TBL] [Abstract][Full Text] [Related]
35. GR46611 potentiates 5-HT1A receptor-mediated locomotor activity in the guinea pig.
O'Neill MF; Sanger GJ
Eur J Pharmacol; 1999 Apr; 370(2):85-92. PubMed ID: 10323255
[TBL] [Abstract][Full Text] [Related]
36. Profile of action of a novel 5-hydroxytryptamine1A receptor ligand E-4424 to inhibit aversive behavior in the mouse, rat and marmoset.
Costall B; Domeney AM; Farre AJ; Kelly ME; Martinez L; Naylor RJ
J Pharmacol Exp Ther; 1992 Jul; 262(1):90-8. PubMed ID: 1352556
[TBL] [Abstract][Full Text] [Related]
37. [[(Arylpiperazinyl)alkyl]thio]thieno[2,3-d]pyrimidinone derivatives as high-affinity, selective 5-HT1A receptor ligands.
Modica M; Santagati M; Russo F; Parotti L; De Gioia L; Selvaggini C; Salmona M; Mennini T
J Med Chem; 1997 Feb; 40(4):574-85. PubMed ID: 9046348
[TBL] [Abstract][Full Text] [Related]
38. Structure-affinity relationship studies on 5-HT1A receptor ligands. 2. Heterobicyclic phenylpiperazines with N4-aralkyl substituents.
van Steen BJ; van Wijngaarden I; Tulp MT; Soudijn W
J Med Chem; 1994 Aug; 37(17):2761-73. PubMed ID: 8064803
[TBL] [Abstract][Full Text] [Related]
39. Selective in vivo labelling of brain 5-HT1A receptors by [3H]WAY 100635 in the mouse.
Laporte AM; Lima L; Gozlan H; Hamon M
Eur J Pharmacol; 1994 Dec; 271(2-3):505-14. PubMed ID: 7705451
[TBL] [Abstract][Full Text] [Related]
40. Intrinsic activity and comparative molecular dynamics of buspirone analogues at the 5-HT(1A) receptors.
Strzelczyk AA; Jarończyk M; Chilmonczyk Z; Mazurek AP; Chojnacka-Wójcik E; Sylte I
Biochem Pharmacol; 2004 Jun; 67(12):2219-30. PubMed ID: 15163553
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
